Advertisement
News
Subscribe to MDT Magazine News

Invensense: First MPU with integrated 3-axis gyro, 3-axis accelero and 9-axis sensor fusion

November 9, 2010 4:38 am | by I-Micronews | Comments

MPU-6000? offers integration of Gyros and Accels on a single silicon die in a 4x4x0.9 mm QFN with on board intelligence to perform 9-axis sensor fusion for quick and easy adoption.

PLC Systems sells business unit for $1M

November 9, 2010 4:37 am | by Mass High Tech: The Journal of New England Technology | Comments

PLC Systems Inc., a medical device technology firm in Franklin, has agreed to sell all of its assets from its Transmyocardial Revascularization (TMR) business for $1 million to Novadaq Technologies Inc., a developer of operating room imaging systems.

Arcadia Resources Announces Improved Fiscal 2011 Second Quarter Results

November 9, 2010 4:36 am | by Bio-Medicine.Org | Comments

INDIANAPOLIS, Nov. 9, 2010 /- Arcadia Resources, Inc. (NYSE Amex: KAD ), a leading provider of innovative consumer health care services under the Arcadia HealthCare(SM) brand, today announced fiscal 2011 second quarter net revenues of $25.8 million and a net loss of $2.9 million, or $0.02...

TOPICS:
Advertisement

Boston Scientific Begins Patient Enrollment in Clinical Trial Assessing Deep Brain Stimulation for Parkinson's Disease

November 9, 2010 4:36 am | by Boston Scientific | Comments

Company implants its first Deep Brain Stimulation device designed to treat Parkinson's

TOPICS:

The Acute Ischemic Stroke Drug Market Will Remain Relatively Flat, Increasing from $460 Million in 2009 to Approximately $610 Million in 2019

November 9, 2010 4:36 am | by Bio-Medicine.Org | Comments

BURLINGTON, Mass., Nov. 9, 2010 /- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the acute ischemic stroke (AIS) drug market will remain relatively flat, increasing from $460 million in 2009 to approximately...

TOPICS:

Onyx Pharmaceuticals Announces Data Presentations Highlighting Carfilzomib Development Program at 52nd American Society of Hematology Annual Meeting

November 9, 2010 4:35 am | by Bio-Medicine.Org | Comments

EMERYVILLE, Calif., Nov. 9, 2010 /- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced the presentation of several studies evaluating carfilzomib, a selective, next-generation proteasome inhibitor, at the American Society of Hematology (ASH) Annual Meeting, December 4-7, 2010, at...

TOPICS:

Abaxis, Inc. to Present at Stephens Fall Investment Conference

November 9, 2010 4:35 am | by Bio-Medicine.Org | Comments

UNION CITY, Calif., Nov. 9, 2010 /- Abaxis, Inc. (Nasdaq: ABAX ), a medical products company manufacturing point-of-care blood analysis systems, announced today that Donald Wood, chief operations officer, will present at the Stephens Fall Investment Conference on Wednesday, November 17,...

TOPICS:

CRi Launches the TRIO™ Multispectral Imaging System for Multi-Analyte Investigation in Tissue

November 9, 2010 4:35 am | by Bio-Medicine.Org | Comments

WOBURN, Mass., Nov. 9, 2010 /- Cambridge Research & Instrumentation, Inc. (CRi), a leader in multicolor imaging solutions for preclinical and clinical research, today announced the newest addition to the award-winning Nuance™ multispectral imaging product family for multicolor...

TOPICS:
Advertisement

NewCardio to Present Results of QTinno Performance on Cardiac Safety Research Consortium Blinded 'Testing' Dataset

November 9, 2010 4:34 am | by Bio-Medicine.Org | Comments

SANTA CLARA, Calif., Nov. 9, 2010 /- NewCardio, Inc. (OTC Bulletin Board: NWCI ), a cardiovascular diagnostic solutions developer, announced today that Dr. Samuel George, NewCardio's Senior Medical Advisor, will present the results of QTinno performance on a blinded "testing" dataset,...

TOPICS:

Safety Investigation of CT Brain Perfusion Scans: Update 11/9/2010

November 9, 2010 4:31 am | by U.S. Food & Drug Administration | Comments

The FDA is issuing this update to inform you of the findings of its investigation of the manufacturers of CT scanners that were the subject of the earlier communications as well as updated recommendations. In addition, this communication summarizes the...

TOPICS:

Invensense® announces the world?s first motionprocessor with integrated 3-axis gyroscope, 3-axis accelerometer and 9-axis sensor fusion

November 9, 2010 1:38 am | by I-Micronews | Comments

MPU-6000? offers integration of Gyros and Accels on a single silicon die in a 4x4x0.9 mm QFN with on board intelligence to perform 9-axis sensor fusion for quick and easy adoption.

PAREXEL International to Participate in the Lazard Capital Markets Healthcare Conference in New York and the Jefferies Healthcare Summit in Boston

November 9, 2010 1:36 am | by Bio-Medicine.Org | Comments

BOSTON, Nov. 9, 2010 /- PAREXEL International Corporation (Nasdaq: PRXL ) announced today it will be presenting at the Lazard Capital Markets Healthcare Conference in New York.  Josef von Rickenbach, Chairman and Chief Executive Officer will be making a presentation on PAREXEL at...

TOPICS:

China BCT Reschedules Conference Call to Discuss Third Quarter 2010 Results

November 9, 2010 1:35 am | by Bio-Medicine.Org | Comments

China BCT Reschedules Conference Call to Discuss Third Quarter 2010... -- LIUZHOU CITY, Guangxi, China, Nov. 9, 2010 /PRNewswire-Asia-FirstCall/ --

TOPICS:

GeneSiC samples multi-kHz, ultra-high-voltage SiC thyristors to US researchers

November 8, 2010 10:35 pm | by I-Micronews | Comments

In what is claimed to be a first of its kind, GeneSiC Semiconductor Inc of Dulles, VA, USA has made available a family of 6.5kV SCR-mode silicon carbide (SiC) thyristors for use in power electronics for smart-grid applications.

Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments

November 8, 2010 10:34 pm | by Bio-Medicine.Org | Comments

SAN DIEGO, Nov. 9, 2010 /- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) today reported financial results for the third quarter ended September 30, 2010. Arena also reported earlier today top-line results from its lorcaserin Phase 3 BLOOM-DM (Behavioral modification and Lorcaserin for...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading